Reihaneh Mortazavi Ardestani | Medicine and Dentistry | Best Researcher Award

Dr. Reihaneh Mortazavi Ardestani | Medicine and Dentistry | Best Researcher Award

Author at Tehran University of Medical Sciences, Iran

Dr. Lígia O Martins is a distinguished researcher and academic specializing in the field of biomedical sciences, particularly in areas related to biomaterials, tissue engineering, and regenerative medicine. She has built a strong academic and professional career with a focus on innovation in material design, bioengineering, and translational research for medical applications. Dr. Martins is recognized for her expertise in the development of bioactive materials that promote tissue regeneration, including studies on the integration of polymers, ceramics, and other advanced biomaterials in medical applications. Throughout her career, Dr. Martins has contributed significantly to the academic and scientific communities, publishing numerous papers, receiving awards, and leading several high-impact research projects. Her work has been influential in advancing the understanding of how biomaterials can be used to address critical healthcare needs, particularly in orthopedics, wound healing, and tissue repair.

Professional Profile

Education:

Dr. Lígia O Martins holds a Ph.D. in Bioengineering, with a strong background in materials science, obtained from a prestigious institution. Her academic journey includes a Bachelor’s degree in Biology, followed by a Master’s in Biotechnology, which laid the foundation for her doctoral studies. Throughout her education, she has demonstrated exceptional scientific curiosity and dedication to advancing her understanding of biomaterials. Her educational path has not only enhanced her scientific knowledge but also fostered an interdisciplinary approach to problem-solving, combining biological sciences with engineering principles to develop novel biomaterials for medical use. The culmination of her education provided Dr. Martins with a comprehensive skill set that integrates both theoretical knowledge and practical expertise in biomedical research.

Professional Experience:

Dr. Lígia O Martins has accumulated extensive professional experience across academia, industry, and research institutions. She has held key academic positions in renowned universities, contributing as a faculty member and principal investigator in multiple research projects. Her professional journey also includes collaborations with industry leaders in the fields of biomaterials, biotechnology, and medical devices, where she has applied her research in practical settings. Dr. Martins has served as a mentor to graduate and postdoctoral students, fostering the next generation of scientists in the field of biomedical engineering. She has also contributed to various international research consortiums and has been involved in the management of large-scale research projects aimed at solving real-world medical challenges, particularly those related to tissue regeneration and biomaterial development.

Research Interests:

Dr. Lígia O Martins’ research interests lie at the intersection of biomaterials, tissue engineering, and regenerative medicine. She is particularly focused on the design and development of bioactive materials that can enhance tissue regeneration and repair. Her work involves the creation of novel biomaterial scaffolds for use in bone, cartilage, and soft tissue regeneration, as well as the incorporation of growth factors and other bioactive molecules to improve healing outcomes. Dr. Martins is also interested in the design of materials that are biocompatible and capable of interacting favorably with biological tissues to promote the regeneration of damaged or diseased tissues. Her research spans areas such as the development of injectable hydrogels, 3D-printed scaffolds, and hybrid materials that combine polymers and ceramics for medical applications.

Research Skills:

Dr. Lígia O Martins possesses a diverse skill set in both experimental and computational research. She is proficient in the design and synthesis of novel biomaterials, with a strong emphasis on polymer chemistry, material characterization, and mechanical testing. Her research skills also extend to cell culture techniques, including the analysis of cell-material interactions, tissue regeneration assays, and the assessment of material biocompatibility. In addition, Dr. Martins has significant experience with advanced imaging techniques, such as scanning electron microscopy (SEM) and confocal microscopy, for analyzing material structures and biological responses. She is skilled in the use of various analytical tools for evaluating the properties of materials, such as mechanical testing, biodegradability studies, and in vitro biological assays. Her multidisciplinary approach combines engineering principles with biological insights, making her highly skilled in conducting research at the interface of material science and biology.

Awards and Honors:

Throughout her career, Dr. Lígia O Martins has received numerous awards and honors recognizing her contributions to the field of biomedical research. She has been acknowledged for her excellence in research and her ability to translate scientific discoveries into practical applications. Dr. Martins has received prestigious fellowships and research grants that have enabled her to lead innovative projects on biomaterials and regenerative medicine. She has also been the recipient of awards for her exceptional publications in top-tier scientific journals, which have been cited extensively in the field. In addition, Dr. Martins has been invited to present her research at various international conferences, further solidifying her reputation as a leader in the biomaterials and tissue engineering fields. These accolades highlight her outstanding impact on the scientific community and her commitment to advancing healthcare through innovative research.

Conclusion:

Reihaneh Mortazavi Ardestani is a highly capable and promising researcher in the field of radiology, with significant accomplishments in clinical practice, teaching, and innovative research. Her dedication to advancing medical imaging, particularly through AI applications, positions her as an excellent candidate for the Best Researcher Award. Further development in leadership roles and international collaborations would enhance her already impressive career trajectory.

Prem Shankar Mishra | Pharmaceutical Science | Best Researcher Award

Dr. Prem Shankar Mishra | Pharmaceutical Science | Best Researcher Award

Professor at Galgotias University, India

Dr. Prem Shankar Mishra is a distinguished academician and pharmaceutical scientist currently serving as Associate Professor and Head of the D.Pharm Programme at Galgotias University. With over a decade of experience in teaching, research, and academic administration, he has established himself as a result-oriented educator and innovative researcher in pharmaceutical sciences. His expertise spans drug design, heterocyclic synthesis, molecular docking, anticancer research, and analytical characterization techniques. Dr. Mishra has successfully guided undergraduate and diploma pharmacy students while contributing significantly to curriculum development, accreditation processes, and outcome-based education systems. He has published numerous research articles in reputed international journals and authored book chapters with global publishers. In addition to his academic contributions, he holds multiple granted Indian and international patents in the fields of pharmaceutical formulations, synthetic chemistry, and biomedical devices. His leadership roles in NAAC/NBA accreditation activities and conference organization reflect his administrative competence and commitment to quality education. Dr. Mishra integrates research innovation with academic excellence, promoting interdisciplinary collaboration and fostering a culture of scientific inquiry. His professional journey reflects dedication to advancing pharmaceutical education and impactful drug discovery research.

Professional Profile

Education

Dr. Prem Shankar Mishra possesses a strong and multidisciplinary academic foundation in pharmacy and law. He completed his Ph.D. in Pharmacy from VISTAS in 2021, focusing on the design, synthesis, and evaluation of 2-pyridone derivatives as potential anticancer agents. His doctoral research emphasized drug design, heterocyclic synthesis, molecular docking, and in-vitro anticancer evaluation under expert supervision from NIPER Kolkata leadership. He earned his Master of Pharmacy (M.Pharm) in Pharmaceutical Chemistry from The Tamil Nadu Dr. M.G.R. Medical University in 2010, building strong expertise in synthetic chemistry and analytical techniques. Earlier, he completed his Bachelor of Pharmacy (B.Pharm) from an institution affiliated with Uttar Pradesh Technical University in 2007. Expanding his interdisciplinary knowledge, he also obtained a Bachelor of Laws (LL.B.) degree from Chaudhary Charan Singh University in 2017. His educational background combines pharmaceutical sciences, research methodology, regulatory awareness, and legal understanding, enabling him to contribute effectively to academic leadership, patent development, and regulatory compliance in higher education and pharmaceutical research.

Professional Experience

Dr. Prem Shankar Mishra has more than ten years of comprehensive experience in teaching, research supervision, and academic administration. Since December 2017, he has been serving as Associate Professor in the Department of Pharmacy at Galgotias University, where he also holds the position of Head of the D.Pharm Programme. In this role, he oversees curriculum implementation, faculty coordination, accreditation processes, regulatory compliance with PCI, NAAC, and NBA standards, and academic planning aligned with outcome-based education under the Washington Accord framework. Prior to this, he worked as Assistant Professor at Meerut Institute of Engineering and Technology from 2010 to 2017, contributing to undergraduate and postgraduate pharmacy education. He also gained early teaching experience as a guest lecturer at Government Polytechnic College, Lakhimpur Kheri. Beyond classroom teaching, Dr. Mishra has organized international conferences, participated in faculty development programs, and served as an external examiner for pharmacy institutions. His professional journey reflects consistent academic growth, leadership in quality assurance initiatives, student mentorship, and active engagement in research-driven pharmaceutical education and institutional development.

Research Interests

Dr. Prem Shankar Mishra’s research interests are centered on pharmaceutical chemistry with a strong emphasis on anticancer drug discovery and development. His primary focus includes the design, synthesis, and characterization of heterocyclic compounds, particularly 2-pyridone and pyridazine derivatives, for potential therapeutic applications. He actively integrates in-silico molecular docking studies with wet-lab synthesis and biological evaluation to accelerate rational drug design. His expertise extends to cell culture-based assays such as MTT assays, flow cytometry (FACS), cell cycle analysis, and reactive oxygen species studies for evaluating cytotoxic effects. Dr. Mishra is also interested in green synthesis approaches, nano-formulations, transdermal delivery systems, and advanced analytical techniques including IR, NMR, HPLC, and UV spectroscopy. He has contributed to computational drug discovery, deep learning applications in site-specific drug delivery, and immunotherapy-based strategies targeting skin cancer. His interdisciplinary research approach bridges synthetic organic chemistry, computational modeling, pharmacological screening, and formulation science. Through funded proposals and patented innovations, he continues to explore novel bioactive molecules and advanced drug delivery systems aimed at improving therapeutic efficacy and safety.

Awards and Honors

Dr. Prem Shankar Mishra has received notable recognition for his academic and research contributions in pharmaceutical sciences. He has secured multiple granted Indian and international patents, including innovations in nanoemulgel formulations, pyridazine derivatives, antimicrobial devices, and transdermal drug delivery systems. His research initiatives have attracted funding support, including a grant from DRDO for organizing a national conference, reflecting institutional trust in his academic leadership. He has actively participated in national and international conferences, winning awards such as first prize in oral presentation during National Pharmacy Week. Dr. Mishra has completed several prestigious NPTEL-AICTE and AICTE-ATAL sponsored faculty development programs focusing on accreditation, patent creation, outcome-based education, and innovative pedagogy. His involvement as a core team member in NAAC/NBA accreditation processes highlights his commitment to maintaining academic quality standards. Additionally, he has served as an external examiner and evaluator for pharmacy institutions. These achievements demonstrate his dedication to academic excellence, research innovation, patent development, professional training, and continuous professional growth in pharmaceutical education and drug discovery research.

Conclusion

Dr. Prem Shankar Mishra exemplifies a balanced integration of academic excellence, innovative research, and effective leadership in pharmaceutical sciences. With strong qualifications in pharmacy and law, extensive teaching experience, and active engagement in drug discovery research, he has made meaningful contributions to anticancer therapeutics, molecular modeling, and pharmaceutical formulation development. His granted patents and funded research proposals reflect his commitment to translational research and practical innovation. As an academic leader at Galgotias University, he plays a vital role in curriculum development, accreditation processes, and outcome-based education implementation. His ability to combine computational drug design, synthetic chemistry, biological evaluation, and regulatory understanding demonstrates interdisciplinary strength. Through mentorship, research publications, conference organization, and policy contributions, he continues to foster scientific inquiry and academic quality. Dr. Mishra’s career trajectory highlights sustained dedication to advancing pharmaceutical education, strengthening research culture, and contributing to impactful drug development strategies aimed at addressing critical healthcare challenges.

Publication Top Noted

  1. Natural Metabolites as Modulators of Sensing and Signaling Mechanisms: Unlocking Anti-Ovarian Cancer Potential
    Year: 2025
    📝 Contributors: Megha Verma, Prem Shankar Mishra, S.K. Abdul Rahaman, Tanya Gupta, Abid Ali Sheikh, Ashok Kumar Sah, and international collaborators
    📚 Journal: Biomedicines
    📌 Type: Review • Open Access
    📊 Citations: 1
  2. Implementation of QKD-Based System Using Nano PCF for Healthcare Applications
    Year: 2025
    Contributors: A.K. Vyas, A. Dixit, S. Tiwari, Prem Shankar Mishra, D.K. Gupta, S. Srivastava, V. Singh
    Journal: Sensing and Bio-Sensing Research
  3. AI-Assisted Immunology for Precision Cancer Medicine
    Year: 2025
    Contributors: Ashok Kumar Sah, Megha Verma, Prem Shankar Mishra, S.K. Abdul Rahaman, Tanya Gupta, and co-authors
    Citations: 1

Hassan Khan Ahmed | Medicine and Dentistry | Best Researcher Award

Dr. Hassan Khan Ahmed | Medicine and Dentistry | Best Researcher Award

Medical Doctor at Neuroscience Research group Stavanger and Sandtangen Clinic, Norway

Hassan Khan Ahmed is a dedicated and experienced medical doctor specializing in neurology. With over a decade of clinical and research experience in Norway and Denmark, he has honed his skills in diagnosing and treating a variety of neurological disorders, particularly stroke-related conditions. He is a passionate physician known for his empathy and dedication to patient care, continuously contributing to research in cerebrovascular diseases. He is also an active member of several medical institutions and has facilitated medical simulations to improve emergency care.

Profile 

ORCID Profile

Education 🎓

Hassan completed his medical education at Southern University of Denmark, earning a Candidatus Medicinae in 2011. His academic journey began with a Bachelor’s degree in Biochemistry from Copenhagen University, followed by a Master’s in Medicine in 2011. Later, he pursued a PhD at the University of Bergen, focusing on thrombolysis in MRI wake-up stroke, a pivotal area in modern neurology. His educational background reflects his commitment to mastering both clinical and research aspects of medicine.

Professional Experience 💼

Hassan’s career is a testament to his diverse expertise in general medicine and neurology. He has served in various capacities, from a general physician to a senior consultant neurologist in renowned medical institutions like Stavanger University Hospital and Klepp & Time Legevakt. His role as a Medical Doctor spans general practice, emergency medicine, and neurology, particularly with stroke care and diagnostics. Throughout his career, he has contributed significantly to improving patient outcomes and has been involved in local research projects like the Stroke Finder Project.

Research Interests 🔬

Hassan’s research is deeply rooted in neurology, with a keen focus on cerebrovascular diseases. His work on thrombolysis in MRI wake-up stroke has gained significant attention, reflecting his dedication to advancing stroke treatment. He has been involved in numerous projects that integrate research and clinical work, such as the Nor-Fib Study and simulations for emergency stroke management. His passion for research drives him to continuously explore ways to improve diagnostic techniques and patient care in neurology.

Awards & Honors 🏆

Hassan has been recognized for his contributions to the medical field, particularly in neurology. Although specific awards were not detailed, his progression to becoming a specialist in neurology in Norway, Denmark, and Sweden in 2019 highlights the recognition of his expertise. His role as a local project manager and facilitator in stroke research projects underscores his leadership and commitment to innovation in healthcare.

Publications 📚

Hassan has made valuable contributions to medical literature, primarily in the field of stroke and neurology. His PhD thesis, titled “Thrombolysis in MRI Wake-up Stroke based on MRI mismatch”, is a notable example of his research efforts. Unfortunately, specific publication links or journals were not provided, but his ongoing work in cerebrovascular diseases has likely been cited in related stroke research.

Conclusion 🔍

Hassan Khan Ahmed is a compassionate and skilled neurologist with a solid foundation in both clinical practice and research. His journey from general medicine to specializing in neurology reflects his commitment to improving patient outcomes, particularly in the treatment of stroke. With continuous involvement in research and a strong educational background, Hassan remains an integral part of the medical community, contributing to innovations in neurology and patient care. His ability to bridge the gap between research and practice makes him a highly respected figure in his field.

Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Prof Dr. Suvi M Virtanen | Medicine and Dentistry | Best Researcher Award

Research Professor, Finnish Institute for Health and Welfare , Finland

The candidate is a distinguished researcher with an MD and PhD from the University of Helsinki, showcasing extensive expertise in medicine and research. Currently serving as a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, the candidate has demonstrated outstanding leadership in public health and nutrition research. Their professional experience includes key roles in major national and international projects, reflecting a strong commitment to advancing public health. As a principal investigator and collaborator in high-profile studies, they have significantly contributed to understanding nutrition’s role in chronic diseases, particularly type 1 diabetes. The candidate’s prolific publication record in leading scientific journals highlights their influential research and impact on the field. With a career marked by academic excellence, significant leadership, and groundbreaking research, the candidate stands out as a leading expert and is highly suitable for the Best Researcher Award.

 

Profile:

Education

The candidate obtained their medical degree (MD) in 1983 and a doctorate (PhD) in 1992 from the University of Helsinki, one of the leading research universities in Finland. Their educational background reflects a strong foundation in medicine and research, particularly in public health and epidemiology. The dual qualifications of MD and PhD highlight the candidate’s commitment to bridging clinical practice with scientific inquiry. Throughout their academic journey, they developed a deep understanding of medical sciences and advanced research methodologies, equipping them to tackle complex health challenges. This combination of medical and research training has enabled them to contribute significantly to the fields of nutrition and epidemiology. Their education not only established their expertise but also set the stage for a successful career marked by leadership roles and impactful research. The candidate’s academic achievements demonstrate a lifelong dedication to learning and advancing health sciences, underpinning their professional success.

 

Professional Experiences 

The candidate has an extensive professional background characterized by leadership roles in public health and epidemiology. Currently, they serve as a Research Professor at the Finnish Institute for Health and Welfare (THL) and as a Professor of Epidemiology at Tampere University, demonstrating a strong commitment to advancing health sciences. They also manage projects related to child health at Tampere University Hospital, showcasing their dedication to improving pediatric health outcomes. Previously, they were the Head of the Nutrition Unit at THL and have held multiple academic and research roles, including positions as a visiting researcher at the London School of Hygiene and Tropical Medicine and as a visiting professor at the University of Colorado Health Sciences Center. Their international experience, combined with years of service in various national health councils and academic positions, highlights their multidisciplinary expertise and ability to lead significant research initiatives in nutrition, epidemiology, and public health.

 

Research Interests

The candidate’s research interests focus on the intersection of nutrition, epidemiology, and public health, with a strong emphasis on understanding the role of diet in the prevention and development of chronic diseases, particularly type 1 diabetes and autoimmune conditions. They have led numerous large-scale, longitudinal studies that explore how dietary patterns, early nutrition, and environmental factors influence disease risk from childhood through adulthood. Their work aims to identify critical dietary determinants of health, unraveling complex interactions between genetics, immune response, and lifestyle factors. The candidate’s research also extends to nutritional epidemiology, investigating the impact of maternal and infant nutrition on long-term health outcomes. Through participation in international consortia and collaborations, they have contributed significantly to advancing scientific knowledge on immune-mediated diseases and dietary interventions. Their ultimate goal is to inform public health policies and develop evidence-based dietary guidelines that promote disease prevention and enhance the quality of life across populations.

 

Research Skills

The candidate demonstrates exceptional research skills characterized by a robust blend of scientific rigor, leadership, and multidisciplinary collaboration. As a Research Professor at the Finnish Institute for Health and Welfare, they lead innovative studies that address critical public health challenges, particularly in the fields of nutrition and epidemiology. Their expertise is further showcased by their involvement in international projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring initiatives, where they serve as a principal investigator. The candidate’s prolific publication record in high-impact journals underscores their ability to produce meaningful, data-driven insights that influence the scientific community and public health policies. They have consistently contributed to groundbreaking research on the relationship between diet and chronic diseases, including type 1 diabetes, through methodologically sound studies. Their ability to manage complex research projects and guide multidisciplinary teams highlights their outstanding research skills and commitment to advancing scientific knowledge for societal benefit.

 

Award And Recognition 

The candidate’s outstanding contributions to nutrition and epidemiological research have earned them significant recognition within the scientific community. As a Research Professor at the Finnish Institute for Health and Welfare and a Professor of Epidemiology at Tampere University, they have led pioneering studies that address critical public health issues, including dietary impacts on autoimmune diseases. Their work has been published extensively in high-impact journals, and they are regularly invited to contribute to key international research collaborations, such as the EU-consortium Zero Hidden Hunger. They have played pivotal roles as principal investigator and committee member in numerous landmark studies, demonstrating exceptional leadership and expertise. The candidate’s dedication to advancing the fields of nutrition and public health has not only influenced policy but also improved health outcomes globally. Their achievements reflect a distinguished career marked by impactful research, academic leadership, and a commitment to enhancing the well-being of populations worldwide.

 

Conclusion

Based on the candidate’s comprehensive qualifications and achievements, they are highly deserving of the Best Researcher Award. With an extensive educational background that includes an MD and PhD from the University of Helsinki, the candidate has built a robust foundation in medical and research expertise. Their professional experience spans multiple high-impact roles, including Research Professor at the Finnish Institute for Health and Welfare and Professor of Epidemiology at Tampere University. They have demonstrated exceptional leadership in numerous significant research projects, such as the EU-consortium Zero Hidden Hunger and national nutrition monitoring programs. The candidate’s prolific publication record in top-tier journals, particularly on diet and autoimmune diseases like type 1 diabetes, highlights their contribution to advancing public health knowledge. Their multidisciplinary expertise, international collaborations, and commitment to impactful research establish them as a leading figure in their field, making them an outstanding candidate for this award.

 

Publication Top Notes

  1. Title: Early-pregnancy BMI, maternal gestational weight gain, and asthma and allergic diseases in children
    Authors: Ojwang’, V., Nwaru, B.I., Hanna-Mari, T., … Knip, M., Virtanen, S.M.
    Journal: Pediatric Allergy and Immunology
    Year: 2024
    Citations: 0
  2. Title: High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes—The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) Study
    Authors: Niinistö, S., Cuthbertson, D., Miettinen, M.E., … Savilahti, E., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  3. Title: Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child
    Authors: Hakola, L., Lund-Blix, N.A., Takkinen, H.-M., … Aki, S., Marja, R.
    Journal: Clinical Nutrition ESPEN
    Year: 2024
    Citations: 0
  4. Title: Gut Inflammation Markers, Diet, and Risk of Islet Autoimmunity in Finnish Children – A Nested Case-Control Study
    Authors: Salo, T.E., Hakola, L., Niinistö, S., … Knip, M., Virtanen, S.M.
    Journal: Journal of Nutrition
    Year: 2024
    Citations: 0
  5. Title: Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk
    Authors: Bhosale, S.D., Moulder, R., Suomi, T., … Knip, M., Lahesmaa, R.
    Journal: iScience
    Year: 2024
    Citations: 0
  6. Title: Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study
    Authors: Hakola, L., Mramba, L.K., Uusitalo, U., … Norris, J.M., Virtanen, S.M.
    Journal: European Journal of Nutrition
    Year: 2024
    Citations: 1
  7. Title: Detecting potential outliers in longitudinal data with time-dependent covariates
    Authors: Mramba, L.K., Liu, X., Lynch, K.F., … Uusitalo, U.M., Krischer, J.P.
    Journal: European Journal of Clinical Nutrition
    Year: 2024
    Citations: 3
  8. Title: Fruit, berry, and vegetable consumption and the risk of islet autoimmunity and type 1 diabetes in children—the Type 1 Diabetes Prediction and Prevention birth cohort study
    Authors: Mattila, M., Takkinen, H.-M., Peltonen, E.J., … Knip, M., Virtanen, S.M.
    Journal: American Journal of Clinical Nutrition
    Year: 2024
    Citations: 1
  9. Title: How prices and income influence global patterns in saturated fat intake by age, sex and world region: a cross-sectional analysis of 160 countries
    Authors: Ahles, A., Muhammad, A., Yenerall, J.N., … Siamusantu, W., Brown, K.
    Journal: BMJ Open
    Year: 2024
    Citations: 0
  10. Title: Periodic mobile application (eMOM) with self-tracking of glucose and lifestyle improves treatment of diet-controlled gestational diabetes without human guidance: a randomized controlled trial
    Authors: Kytö, M., Hotta, S., Niinistö, S., … Heihonen, S., Koivusalo, S.B.
    Journal: American Journal of Obstetrics and Gynecology
    Year: 2024
    Citations: 0

 

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79